Detailed Review Of Prospects For Vor Biopharma Inc Stock

A share price of Vor Biopharma Inc [VOR] is currently trading at $0.91, up 10.06%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VOR shares have gain 5.57% over the last week, with a monthly amount glided 10.73%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on July 26, 2022, when Wedbush initiated its Outperform rating and assigned the stock a price target of $18. Previously, Goldman started tracking the stock with Neutral rating on April 27, 2022, and set its price target to $6. On December 17, 2021, H.C. Wainwright initiated with a Buy rating and assigned a price target of $26 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $38 on December 03, 2021. Oppenheimer initiated its recommendation with a Outperform and recommended $30 as its price target on December 02, 2021. JMP Securities started tracking with a Mkt Outperform rating for this stock on October 19, 2021, and assigned it a price target of $40. In a note dated March 25, 2021, B. Riley Securities initiated an Buy rating and provided a target price of $60 on this stock.

Vor Biopharma Inc experienced fluctuations in its stock price throughout the past year between $0.70 and $3.14. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $0.91 at the most recent close of the market. An investor can expect a potential return of 559.34% based on the average VOR price forecast.

Analyzing the VOR fundamentals

Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -10.21%, Pretax Profit Margin comes in at -9.66%, and Net Profit Margin reading is -9.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.83, Equity is -0.86 and Total Capital is -0.98. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.34.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7987 points at the first support level, and at 0.6893 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0887, and for the 2nd resistance point, it is at 1.2693.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Vor Biopharma Inc [NASDAQ:VOR] is 6.54. As well, the Quick Ratio is 6.54, while the Cash Ratio is 5.51.

Transactions by insiders

Recent insider trading involved Attar Eyal C., CHIEF MEDICAL OFFICER, that happened on Jun 03 ’24 when 14645.0 shares were sold.

Related Posts